JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Financials | 9.75% |
| 3 | Consumer Discretionary | 8.78% |
| 4 | Healthcare | 7.93% |
| 5 | Communication Services | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
PENN Entertainment
PENN
$2.52B
| $846K | ﹤0.01% |
57,349
-1,069,725
| -95% | -$16.7M |
|
4527
indie Semiconductor
INDI
$995M
| $844K | ﹤0.01% |
239,151
-3,105
| -1% | -$13.6K |
|
4528
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.4B
| $844K | ﹤0.01% |
5,276
-288
| -5% | -$46.1K |
|
4529
PubMatic
PUBM
$801M
| $842K | ﹤0.01% |
94,931
-253,254
| -73% | -$2.21M |
|
|
AKRE
4530
Akre Focus ETF
AKRE
$5.4B
| $840K | ﹤0.01% |
+12,822
| New | +$830K |
|
4531
Fox Factory Holding Corp
FOXF
$883M
| $839K | ﹤0.01% |
49,041
-6,265
| -11% | -$119K |
|
4532
BayCom
BCML
$339M
| $836K | ﹤0.01% |
28,427
-7,258
| -20% | -$210K |
|
|
FCRS
4533
FutureCrest Acquisition Corp
FCRS
$368M
| $834K | ﹤0.01% |
+82,588
| New | +$835K |
|
|
MAZE
4534
Maze Therapeutics
MAZE
$1.51B
| $829K | ﹤0.01% |
20,007
+12,117
| +154% | +$416K |
|
4535
PUT
Agios Pharmaceuticals
AGIO
$2B
| $825K | ﹤0.01% |
30,300
+11,900
| +65% | +$418K |
|
4536
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $824K | ﹤0.01% |
5,168
-29,102
| -85% | -$4M |
|
4537
XPEL
XPEL
$1.38B
| $823K | ﹤0.01% |
16,491
-67,769
| -80% | -$2.83M |
|
4538
Wolfspeed
WOLF
$1.65B
| $820K | ﹤0.01% |
47,124
+43,111
| +1,074% | +$989K |
|
4539
Vanguard Long-Term Bond ETF
BLV
$5.7B
| $820K | ﹤0.01% |
11,798
-280,574
| -96% | -$19.9M |
|
4540
Bioventus
BVS
$1.2B
| $819K | ﹤0.01% |
110,090
-4,687
| -4% | -$33.7K |
|
4541
State Street SPDR S&P Semiconductor ETF
XSD
$2.93B
| $818K | ﹤0.01% |
2,545
-4
| -0.2% | -$1.32K |
|
|
4542
CALL
Agios Pharmaceuticals
AGIO
$2B
| $817K | ﹤0.01% |
+30,000
| New | +$1.05M |
|
4543
iShares US Transportation ETF
IYT
$2.28B
| $813K | ﹤0.01% |
10,909
-79,585
| -88% | -$5.78M |
|
4544
Schwab Fundamental International Small Company Index ETF
FNDC
$3.18B
| $812K | ﹤0.01% |
18,216
-691
| -4% | -$30.7K |
|
|
NOAH
4545
Noah Holdings
NOAH
$592M
| $811K | ﹤0.01% |
80,788
+54,298
| +205% | +$590K |
|
4546
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.39B
| $807K | ﹤0.01% |
4,498
+1,264
| +39% | +$222K |
|
4547
Avalo Therapeutics
AVTX
$1.05B
| $807K | ﹤0.01% |
44,431
+42,858
| +2,725% | +$723K |
|
4548
PUT
Futu Holdings
FUTU
$14.8B
| $805K | ﹤0.01% |
4,900
-17,000
| -78% | -$2.92M |
|
|
ELVR
4549
Elevra Lithium Ltd
ELVR
$1.26B
| $804K | ﹤0.01% |
15,300
-4,804
| -24% | -$165K |
|
4550
Amylyx Pharmaceuticals
AMLX
$2.41B
| $804K | ﹤0.01% |
66,547
+30,703
| +86% | +$417K |
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $108B in Q4 2025, closing 563 positions and reducing 3,330 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.